AFB Drug Susceptibility Panel Additional Drugs 4 Nos. MACC By MGIT - Pure Culture
AFB Drug Susceptibility Panel - (4 drugs) MACC, Pure Culture Price
AFB DST Panel Overview
The "AFB Drug susceptibility - Additional drugs 4 Nos. MACC panel by MGIT - Pure Culture" test is a critical diagnostic tool used for tuberculosis (TB) treatment. This test utilizes the MGIT (Mycobacteria Growth Indicator Tube) method on pure cultures of Mycobacterium tuberculosis (MTB) Complex to assess the drug susceptibility of MTB to four additional anti-tuberculosis drugs: Moxifloxacin, Amikacin, Clofazimine, and Capreomycin, collectively known as the MACC panel. The clinical utility of this test lies in its ability to provide essential information to healthcare professionals about the effectiveness of these additional drugs against the MTB Complex causing TB. By evaluating drug susceptibility to these four drugs in combination with other first-line and second-line drugs, this test helps in the management of complex and drug-resistant TB cases. The results enable clinicians to tailor personalized and effective treatment regimens, ensuring optimal care and increasing the chances of successful TB treatment. Overall, the AFB Drug susceptibility - Additional drugs 4 Nos. MACC panel by MGIT plays a crucial role in tuberculosis treatment, providing a comprehensive understanding of drug susceptibility patterns to guide targeted therapy. By enabling the selection of appropriate and effective drug combinations, this test significantly contributes to improved patient outcomes, better management of drug-resistant TB cases, and the overall fight against tuberculosis.
The AFB DST Panel Additional Drugs 4 Nos. MACC By MGIT - Pure Culture is a crucial diagnostic test used to evaluate the susceptibility of Mycobacterium tuberculosis (MTB) to four additional anti-tuberculosis drugs: moxifloxacin, amikacin, clofazimine, and capreomycin (MACC). This test employs the Mycobacteria Growth Indicator Tube (MGIT) method on pure cultures of MTB Complex to determine the effectiveness of these drugs against the bacteria causing tuberculosis (TB).
The AFB DST Panel plays a vital role in managing complex and drug-resistant TB cases by identifying whether the MTB strain is resistant to first-line and second-line anti-TB drugs. The results of the AFB DST Panel enable doctors to tailor personalised and effective treatment regimens for TB patients, ensuring optimal care and increasing the chances of successful treatment outcomes.
Frequently asked questions
Find quick answers to the most common questions about health tests, bookings, and reports.
Regular exercise, a balanced diet, avoiding smoking, maintaining a healthy weight, and managing stress all help reduce heart disease risk.
Common signs include irritability, trouble sleeping, headaches, difficulty concentrating, and muscle tension.
Ratings & Reviews
We're satisfying our customers every day since 1980.
Choose precision On time, every time!
- 98% on time collections with a 60 minutes promise
- Real-time tracking of phlebotomist arrival and report generation
- Fully digital report delivery—view from mobile or desktop instantly
- Continuous monitoring of turnaround times to ensure accuracy and speed
- Dedicated support team to resolve any delays or queries quickly
Why Metropolis Healthcare?
Metropolis has been present for over 40 years in the market.
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
0
Years of experience
170+
Advanced Labs
Trusted by
Leading Doctors & Hospitals
2,000+
Scientific Officers
Proficiency Testing
for Accurate Reports
Latest Blogs & News
Stay informed with our expert insights and updates.
About Us
Metropolis Healthcare is a leading diagnostic service provider in India. We are a team of dedicated professionals committed to ensuring you and your family receive the most accurate and timely healthcare solutions. We believe in making health care accessible, affordable and evidence-based. Our expert panel are equipped with the latest technology and manned by a certified team of over 4000+ technicians.
In diagnostic services, we have more than three decades of experience servicing diverse stakeholders health advantage packages for men, women and seniors, genetic fitness & corporation in over 650+ tests like Oncology, Neurology, Gynaecology, Haematology, and many more. Our diagnostic services are located in leading doctors and clinics and serve over 15+ cities in India.